RT Journal Article
T1 SEOM clinical guidelines for anaplastic gliomas (2017).
A1 Balaña, C
A1 Alonso, M
A1 Hernandez-Lain, A
A1 Hernandez, A
A1 Perez-Segura, P
A1 Pineda, E
A1 Ramos, A
A1 Sanchez, A R
A1 Teixidor, P
A1 Verger, E
A1 Benavides, M
K1 Anaplastic astrocytoma
K1 Anaplastic glioma
K1 Anaplastic oligodendroglioma
AB The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
PB Springer
YR 2017
FD 2017-10-20
LK http://hdl.handle.net/10668/11715
UL http://hdl.handle.net/10668/11715
LA en
NO Balañá C, Alonso M, Hernandez-Lain A, Hernandez A, Perez-Segura P, Pineda E, et al. SEOM clinical guidelines for anaplastic gliomas (2017). Clin Transl Oncol. 2018 Jan;20(1):16-21. doi: 10.1007/s12094-017-1762-7. Epub 2017 Oct 20. Erratum in: Clin Transl Oncol. 2018 Jul;20(7):937
DS RISalud
RD Apr 9, 2025